Purpose: Retinal vascular diameters have recently been shown not to be related to an increased risk of open-angle glaucoma. Because vasospastic propensity has been suggested to represent a risk factor for various ocular diseases, especially glaucoma, the steady-state retinal vascular diameter in subjects with a propensity for systemic vascular dysregulation was compared with a group of age-matched gender-matched controls.

Methods: Thirty healthy non-smoking individuals [female/male 26/4; mean +/- SD age 22.8+/-3.4 (range 18-31) years] were enrolled into the study. Subjects were classified as having vasospasm (15 subjects) if they related a clear history of frequently cold hands and as healthy subjects (15 subjects) if they denied such a history. Vasospastic propensity or the absence of it had to be confirmed by nail-fold capillaroscopy. Vascular diameter of retinal vessels was measured repeatedly on two days with the retinal vessel analyser and corrected for perfusion pressure, age, and refraction.

Results: Neither retinal arteriole diameter (P=0.30) or retinal venule diameter (P=0.49), nor retinal arteriole-to-venule ratio (P=0.96), differed between the two experimental groups.

Conclusions: Although vasospastic propensity has been suggested to represent a risk factor in various ocular diseases, the steady-state retinal vessel diameters are not altered in healthy vasospastic subjects. It is probable that the steady-state retinal vessel diameters are no adequate risk indicators for the haemodynamic risk in diseases such as glaucoma.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00417-005-0101-9DOI Listing

Publication Analysis

Top Keywords

vasospastic propensity
16
retinal vascular
12
vascular diameter
12
steady-state retinal
12
retinal vessel
12
retinal
10
propensity suggested
8
suggested represent
8
represent risk
8
risk factor
8

Similar Publications

Sustained efficacy of angioplasty for cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Risk features and device comparison.

J Clin Neurosci

October 2024

Department of Neurological Surgery, University of Pittsburgh Medical Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, United States. Electronic address:

Background: Cerebral vasospasm is a leading source of delayed morbidity and mortality after aneurysmal subarachnoid hemorrhage (aSAH). Angioplasty may improve vasospasm, while optimal target and device selection remains controversial. This study aimed to identify features and devices associated with sustained efficacy.

View Article and Find Full Text PDF

Which Coronary Artery Should Be Preferred for Starting the Coronary Spasm Provocation Test?

Life (Basel)

October 2023

Department of Cardiovascular Medicine, JR Hiroshima Hospital, 3-1-36, Futabanosato, Higashi-ku, Hiroshima 732-0057, Japan.

Background: The spasm provocation test (SPT) is a critical test for diagnosing vasospastic angina (VSA). However, the choice of vessel to be preferred for initiating the SPT-the right coronary artery (RCA) or the left coronary artery (LCA)-is unclear. This study aimed to assess SPT results including SPT-related complications while initiating the SPT in the RCA and LCA.

View Article and Find Full Text PDF

Background: Although current guidelines recommend beta-blockers (BBs) after acute myocardial infarction (AMI), the role of calcium-channel blockers (CCBs) has not been well investigated, especially nondihydropyridine.

Objectives: This study aimed to compare the effects of CCBs on cardiovascular outcomes compared with BBs in AMI because patients from East Asia have a higher incidence of a vasospastic angina component compared with Western countries.

Methods: Among 15,628 patients enrolled in the KAMIR-V (Korean Acute Myocardial Infarction Registry-V), we evaluated 10,650 in-hospital survivors who were treated with either CCBs or BBs.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the long-term effects of different vasodilators on clinical outcomes in patients with vasospastic angina (VA), using data from a multicenter registry.
  • Patients were divided into two groups based on the vasodilator they received at discharge: nitrates and other vasodilators, with results showing higher rates of adverse events in the nitrates group, including acute coronary syndrome (ACS).
  • The findings indicate that using nitrates can significantly increase the risk of serious complications for VA patients within a year, urging clinicians to consider alternative vasodilators for better patient outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!